Detecting early structural lung damage in cystic fibrosis
1Department of Pediatric Pulmonology, Erasmus MC-University Medical Center Rotterdam, Sophia Children's Hospital, Rotterdam, The Netherlands. tiddens@alkg.azr.nl
Cystic fibrosis (CF) patients show early airway thickening, a sign of lung damage. Reduced peripheral airflow, even with normal lung function tests, indicates significant damage and requires aggressive treatment.
Area of Science:
- Pulmonology
- Medical Imaging
- Respiratory Medicine
Background:
- Cystic fibrosis (CF) is characterized by early and persistent lung inflammation and damage.
- Chest X-rays are less sensitive than high-resolution computed tomography (HRCT) for detecting early structural lung abnormalities in CF.
- Standard lung function tests may not detect localized or early-stage lung damage.
Purpose of the Study:
- To highlight the significance of peripheral airway thickening in early cystic fibrosis lung disease.
- To emphasize the limitations of conventional lung function tests in identifying early structural damage.
- To advocate for the recognition of reduced peripheral airflow as an early indicator of substantial lung damage.
Main Methods:
- Utilizing high-resolution computed tomography (HRCT) to assess airway structural changes.
- Analyzing lung function tests, including forced vital capacity (FVC) and forced expired volume in 1 sec (FEV(1)).
- Measuring maximal expiratory flow at 25% of forced vital capacity (MEF(25)) to evaluate peripheral airflow.
Main Results:
- HRCT reveals substantial thickening of airways in early CF lung disease.
- Thickening of peripheral airways leads to reduced maximal expiratory flow at 25% (MEF(25)).
- Reduced peripheral airflow can occur despite normal FEV(1) and FVC measurements.
Conclusions:
- Reduced peripheral airflow, indicated by decreased MEF(25), is an early sign of significant lung damage in CF patients.
- This finding should prompt aggressive treatment to prevent further lung deterioration.
- Early detection of structural lung damage through sensitive imaging and flow measurements is crucial for CF management.
More Related Videos
03:38Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
